UACR in Diabetes: A Window Into Cardiorenal Risk
Diabetes DiscourseUACR in Diabetes: A Window Into Cardiorenal Risk
Brian P. McDonough, MD, FAAFP
Jennifer B. Green, MD
Who’s Most at Risk? Assessing Progression in IgAN
Clinician's RoundtableWho’s Most at Risk? Assessing Progression in IgAN
Abdallah Geara, MD
Navigating Today’s Treatment Options for IgA Nephropathy
Clinician's RoundtableNavigating Today’s Treatment Options for IgA Nephropathy
Abdallah Geara, MD
How Classification Shapes Treatment in FSGS
Clinician's RoundtableHow Classification Shapes Treatment in FSGS
Abdallah Geara, MD
Finerenone in IgAN: A Proteinuria Signal Worth Following
Clinician's RoundtableFinerenone in IgAN: A Proteinuria Signal Worth Following
Green Tea Compound Shows Potential to Protect Podocytes in FSGS
Clinician's RoundtableGreen Tea Compound Shows Potential to Protect Podocytes in FSGS
- advertisement
- MinuteCE®
The Potassium Shift: Individualizing Hyperkalemia Management With Modern Oral Potassium Binders
James Burton, DM, FRCP
Nihar R. Desai, MD, MPH
Ellie Kelepouris, MD, FACP, FAHA
Pauline A. Swift, PhD
Personalized Treatment Strategies for Hyperkalemia: Bridging Evidence and Clinical Practice Needs
MinuteCE®Personalized Treatment Strategies for Hyperkalemia: Bridging Evidence and Clinical Practice Needs
Ellie Kelepouris, MD, FACP, FAHA
A Case-Based Discussion on Managing Adult Patients With C3G or IC-MPGN in the Era of Complement Inhibition
CME/CEA Case-Based Discussion on Managing Adult Patients With C3G or IC-MPGN in the Era of Complement Inhibition
Kenar D. Jhaveri, MD
Shikha Wadhwani MD, MS
Hyperkalemia as a Barrier to GDMT: Why “Stopping GDMT” Is Often the Wrong Reflex
MinuteCE®Hyperkalemia as a Barrier to GDMT: Why “Stopping GDMT” Is Often the Wrong Reflex
James Burton, DM, FRCP
Nihar R. Desai, MD, MPH
Differentiating Oral Potassium Binders: Mechanism, Onset, and Sodium Load
MinuteCE®Differentiating Oral Potassium Binders: Mechanism, Onset, and Sodium Load
James Burton, DM, FRCP
Ellie Kelepouris, MD, FACP, FAHA
From Lab Alert to Action Plan: Monitoring Potassium Without Undermining Cardiorenal Protection
MinuteCE®From Lab Alert to Action Plan: Monitoring Potassium Without Undermining Cardiorenal Protection
James Burton, DM, FRCP
Pauline A. Swift, PhD
- advertisement
Not Just for Diabetes: Broadening uACR Screening to CV Risk Populations
Conversations in CV Risk AssessmentNot Just for Diabetes: Broadening uACR Screening to CV Risk Populations
Brian P. McDonough, MD, FAAFP
Anu Lala, MD
Unseen Disease: The Diagnostic Barriers to CKD and CV Risk Prevention
Conversations in CV Risk AssessmentUnseen Disease: The Diagnostic Barriers to CKD and CV Risk Prevention
Jennifer Caudle, DO, FACOFP
Dustin Le, MD, MHS
Niloo Nobakht, MD, FASN
Predicting the Heart’s Future: Albuminuria as a CV Warning Sign
Conversations in CV Risk AssessmentPredicting the Heart’s Future: Albuminuria as a CV Warning Sign
Brian P. McDonough, MD, FAAFP
Anu Lala, MD
Heart Failure and Albuminuria: Connecting the Dots
Conversations in CV Risk AssessmentHeart Failure and Albuminuria: Connecting the Dots
Jennifer Caudle, DO, FACOFP
Robert J. Mentz, MD, FHFSA, FACC
Bridging the Gap: From Screening to Cardiovascular Risk Diagnosis
Conversations in CV Risk AssessmentBridging the Gap: From Screening to Cardiovascular Risk Diagnosis
Jennifer Caudle, DO, FACOFP
Dustin Le, MD, MHS
Niloo Nobakht, MD, FASN
The Risk Equation: Combining uACR and eGFR for CV Prediction
Conversations in CV Risk AssessmentThe Risk Equation: Combining uACR and eGFR for CV Prediction
Matthew Sorrentino, MD
Ashish Verma, MBBS
- 10/30/2026
- 10/29/2026
- 10/28/2026
- 10/27/2026
- 10/20/2026
- 10/16/2026